Segall Bryant & Hamill’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
+26,815
| New | +$1.4M | 0.02% | 476 |
|
|
2024
Q1 | – | Sell |
-77,686
| Closed | -$8.51M | – | 307 |
|
|
2023
Q4 | $8.51M | Buy |
77,686
+252
| +0.3% | +$27.6K | 0.16% | 208 |
|
|
2023
Q3 | $7.81M | Sell |
77,434
-491
| -0.6% | -$49.5K | 0.09% | 254 |
|
|
2023
Q2 | $10.6M | Buy |
77,925
+361
| +0.5% | +$49.1K | 0.11% | 226 |
|
|
2023
Q1 | $8.06M | Sell |
77,564
-49,129
| -39% | -$5.1M | 0.09% | 258 |
|
|
2022
Q4 | $11.2M | Buy |
126,693
+8,479
| +7% | +$752K | 0.13% | 203 |
|
|
2022
Q3 | $9.48M | Buy |
118,214
+17,542
| +17% | +$1.41M | 0.11% | 215 |
|
|
2022
Q2 | $9.64M | Buy |
100,672
+29,910
| +42% | +$2.86M | 0.11% | 207 |
|
|
2022
Q1 | $10.5M | Buy |
70,762
+169
| +0.2% | +$25.1K | 0.1% | 210 |
|
|
2021
Q4 | $10M | Buy |
70,593
+3,327
| +5% | +$472K | 0.09% | 212 |
|
|
2021
Q3 | $8.8M | Buy |
67,266
+1,812
| +3% | +$237K | 0.08% | 232 |
|
|
2021
Q2 | $9M | Buy |
65,454
+3,666
| +6% | +$504K | 0.09% | 229 |
|
|
2021
Q1 | $8.07M | Sell |
61,788
-674
| -1% | -$88K | 0.08% | 240 |
|
|
2020
Q4 | $7M | Sell |
62,462
-1,134
| -2% | -$127K | 0.08% | 238 |
|
|
2020
Q3 | $5M | Buy |
63,596
+51,738
| +436% | +$4.07M | 0.07% | 262 |
|
|
2020
Q2 | $853K | Buy |
11,858
+5,362
| +83% | +$386K | 0.01% | 475 |
|
|
2020
Q1 | $372K | Buy |
+6,496
| New | +$372K | 0.01% | 637 |
|